Cargando…

Apolipoprotein B/A1 Ratio as a Diagnostic Alternative to Triglycerides and HDL-Cholesterol for the Prediction of Metabolic Syndrome among Hypertensives in Kazakhstan

Apolipoproteins (Apo) are known atherogenic factors that play important roles in many mechanisms related to coronary heart disease. The ApoB/ApoA1 ratio is a promising diagnostic tool for metabolic syndrome (MS) in different populations, though its use is not established in Kazakhstan. This study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Nurtazina, Alma, Kozhakhmetova, Dana, Dautov, Daulet, Shakhanova, Aizhan, Chattu, Vijay Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459610/
https://www.ncbi.nlm.nih.gov/pubmed/32717783
http://dx.doi.org/10.3390/diagnostics10080510
_version_ 1783576409837404160
author Nurtazina, Alma
Kozhakhmetova, Dana
Dautov, Daulet
Shakhanova, Aizhan
Chattu, Vijay Kumar
author_facet Nurtazina, Alma
Kozhakhmetova, Dana
Dautov, Daulet
Shakhanova, Aizhan
Chattu, Vijay Kumar
author_sort Nurtazina, Alma
collection PubMed
description Apolipoproteins (Apo) are known atherogenic factors that play important roles in many mechanisms related to coronary heart disease. The ApoB/ApoA1 ratio is a promising diagnostic tool for metabolic syndrome (MS) in different populations, though its use is not established in Kazakhstan. This study aimed to assess the relationship between MS and the ApoB/ApoA1 ratio among hypertensive patients and to evaluate its diagnostic use for identifying MS as an alternative to triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C). A cross-sectional study was conducted in 800 eligible men and women with primary hypertension from April 2015 to December 2016. Data were collected on socio-demographics, lifestyle parameters, family history of cardiovascular disease, and hypertension. Dietary Quality Score (DQS), anthropometric data, and blood pressure were recorded; ApoA1 and ApoB levels were measured in blood samples. We found a significant positive association between MS and the ApoB/ApoA1 ratio by multiple logistic regression, as shown by a linear trend of increase of the odds ratio (OR) for MS across the quartiles of ApoB/ApoA1 (p < 0.0001). ROC analysis revealed diagnostic significance of the ApoB/ApoA1 ratio for MS, and comparative ROC analysis demonstrated equal diagnostic value of ApoB/ApoA1 ratio and TG levels (AUC = 0.71 (95% CI 0.69; 0.74) and 0.72 (95% CI 0.69, 0.76), respectively), which was significantly higher than those of HDL, ApoA1, ApoB (AUC = 0.27 (95% CI 0.23; 0.31), AUC = 0.37 (95% CI 0.33; 0.41), AUC = 0.67, (95% CI 0.63; 0.71), respectively). The diagnostic value of the ApoB/ApoA1 ratio in Kazakhs with MS appeared to equal that of TG and was significantly higher than that of HDL-C. Adjusting for gender, smoking, and DQS significantly strengthened the association between MS and the ApoB/ApoA1 ratio in the Kazakh population.
format Online
Article
Text
id pubmed-7459610
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74596102020-09-02 Apolipoprotein B/A1 Ratio as a Diagnostic Alternative to Triglycerides and HDL-Cholesterol for the Prediction of Metabolic Syndrome among Hypertensives in Kazakhstan Nurtazina, Alma Kozhakhmetova, Dana Dautov, Daulet Shakhanova, Aizhan Chattu, Vijay Kumar Diagnostics (Basel) Article Apolipoproteins (Apo) are known atherogenic factors that play important roles in many mechanisms related to coronary heart disease. The ApoB/ApoA1 ratio is a promising diagnostic tool for metabolic syndrome (MS) in different populations, though its use is not established in Kazakhstan. This study aimed to assess the relationship between MS and the ApoB/ApoA1 ratio among hypertensive patients and to evaluate its diagnostic use for identifying MS as an alternative to triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C). A cross-sectional study was conducted in 800 eligible men and women with primary hypertension from April 2015 to December 2016. Data were collected on socio-demographics, lifestyle parameters, family history of cardiovascular disease, and hypertension. Dietary Quality Score (DQS), anthropometric data, and blood pressure were recorded; ApoA1 and ApoB levels were measured in blood samples. We found a significant positive association between MS and the ApoB/ApoA1 ratio by multiple logistic regression, as shown by a linear trend of increase of the odds ratio (OR) for MS across the quartiles of ApoB/ApoA1 (p < 0.0001). ROC analysis revealed diagnostic significance of the ApoB/ApoA1 ratio for MS, and comparative ROC analysis demonstrated equal diagnostic value of ApoB/ApoA1 ratio and TG levels (AUC = 0.71 (95% CI 0.69; 0.74) and 0.72 (95% CI 0.69, 0.76), respectively), which was significantly higher than those of HDL, ApoA1, ApoB (AUC = 0.27 (95% CI 0.23; 0.31), AUC = 0.37 (95% CI 0.33; 0.41), AUC = 0.67, (95% CI 0.63; 0.71), respectively). The diagnostic value of the ApoB/ApoA1 ratio in Kazakhs with MS appeared to equal that of TG and was significantly higher than that of HDL-C. Adjusting for gender, smoking, and DQS significantly strengthened the association between MS and the ApoB/ApoA1 ratio in the Kazakh population. MDPI 2020-07-23 /pmc/articles/PMC7459610/ /pubmed/32717783 http://dx.doi.org/10.3390/diagnostics10080510 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nurtazina, Alma
Kozhakhmetova, Dana
Dautov, Daulet
Shakhanova, Aizhan
Chattu, Vijay Kumar
Apolipoprotein B/A1 Ratio as a Diagnostic Alternative to Triglycerides and HDL-Cholesterol for the Prediction of Metabolic Syndrome among Hypertensives in Kazakhstan
title Apolipoprotein B/A1 Ratio as a Diagnostic Alternative to Triglycerides and HDL-Cholesterol for the Prediction of Metabolic Syndrome among Hypertensives in Kazakhstan
title_full Apolipoprotein B/A1 Ratio as a Diagnostic Alternative to Triglycerides and HDL-Cholesterol for the Prediction of Metabolic Syndrome among Hypertensives in Kazakhstan
title_fullStr Apolipoprotein B/A1 Ratio as a Diagnostic Alternative to Triglycerides and HDL-Cholesterol for the Prediction of Metabolic Syndrome among Hypertensives in Kazakhstan
title_full_unstemmed Apolipoprotein B/A1 Ratio as a Diagnostic Alternative to Triglycerides and HDL-Cholesterol for the Prediction of Metabolic Syndrome among Hypertensives in Kazakhstan
title_short Apolipoprotein B/A1 Ratio as a Diagnostic Alternative to Triglycerides and HDL-Cholesterol for the Prediction of Metabolic Syndrome among Hypertensives in Kazakhstan
title_sort apolipoprotein b/a1 ratio as a diagnostic alternative to triglycerides and hdl-cholesterol for the prediction of metabolic syndrome among hypertensives in kazakhstan
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459610/
https://www.ncbi.nlm.nih.gov/pubmed/32717783
http://dx.doi.org/10.3390/diagnostics10080510
work_keys_str_mv AT nurtazinaalma apolipoproteinba1ratioasadiagnosticalternativetotriglyceridesandhdlcholesterolforthepredictionofmetabolicsyndromeamonghypertensivesinkazakhstan
AT kozhakhmetovadana apolipoproteinba1ratioasadiagnosticalternativetotriglyceridesandhdlcholesterolforthepredictionofmetabolicsyndromeamonghypertensivesinkazakhstan
AT dautovdaulet apolipoproteinba1ratioasadiagnosticalternativetotriglyceridesandhdlcholesterolforthepredictionofmetabolicsyndromeamonghypertensivesinkazakhstan
AT shakhanovaaizhan apolipoproteinba1ratioasadiagnosticalternativetotriglyceridesandhdlcholesterolforthepredictionofmetabolicsyndromeamonghypertensivesinkazakhstan
AT chattuvijaykumar apolipoproteinba1ratioasadiagnosticalternativetotriglyceridesandhdlcholesterolforthepredictionofmetabolicsyndromeamonghypertensivesinkazakhstan